self-monitoring for patients with severe COPD
OtherIntervention Group entering vital parameters via Web Portal or automatic call center.
NCT Number: NCT01580072
Evaluation whether the introduction of large-scale telemonitoring of patients with COPD produces benefits in terms of reduced hospital readmissions, improved health related quality of life and health status. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
LKH Laas, Kötschach, Carintha, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurses are entering vital parameters of the patient with mobile devices.
Time frame: 12 months
Baseline analyses and analyses after 12 months were conducted. Normal distribution is not given for SF-36 scales, means and Standard Deviation are reported. A high score defines a more favorable health state, items are scored on a 0 to 100 range. Scale scores represent the average for all items in the scale that the respondent answered.
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Not all data were available, so only participants with consistent data were taken into comparison, this lead to a lower number of patients in this outcome measurement.
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
deceased patients in respect to participating patients, by obituary column
Time frame: 12 months
No data available
Time frame: 12 months
The SGRQ is a 50-item questionnaire developed to measure health status (quality of life) in patients with diseases of airways obstruction.
Scores are calculated for three domains:
Symptoms, Activity and Impacts as well as a total score. Psychometric testing has demonstrated its repeatability, reliability and validity. Sensitivity has been demonstrated in clinical trials.
A minimum change in score of 4 units was established as clinically relevant after patient and clinician testing. The SGRQ has been used in a range of disease groups including asthma, chronic obstructive pulmonary disease (COPD) and bronchiectasis, and in a range of settings such as randomised controlled therapy trials and population surveys.Due to missing data not all questoinnaires could be taken into consideration. Normal distribution is not given for SGRQ scales; Scores are expressed as a percentage of overall impairment where 100 represents worst possible health status and 0 indicates best pos
Time frame: 12 months
Landeskrankenanstalten-Betriebsgesellschaft
Industry
REgions of Europe WorkiNg toGether for HEALTH (Renewing Health)
Acronym: RenewingHealth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07497230
Chronic Disease, Disease Attributes
Santiago, Chile
View Trial DetailsNCT05915182
Chronic Disease, Disease Attributes
Alexandroupoli, Greece
View Trial DetailsNCT03269721
Chronic Disease, Cognition Disorders
Iowa City, Iowa, United States
View Trial DetailsNCT02596009
Atrophy, Body Weight
CABA, Buenos Aires, Argentina
View Trial Details